Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies-Reference-Cited by-同舟云学术

Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies

Published:2016-10-20 Issue:47 Volume:7 Page:77021-77037
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Jahn Lorenz¹,van der Steen Dirk M.¹,Hagedoorn Renate S.¹,Hombrink Pleun¹²,Kester Michel G.D.¹,Schoonakker Marjolein P.¹,de Ridder Daniëlle¹,van Veelen Peter A.³⁴,Falkenburg J.H. Frederik¹,Heemskerk Mirjam H.M.¹

Affiliation:

1. Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands

2. Department of Hematopoiesis, Sanquin Research, 1006 AD Amsterdam, The Netherlands

3. Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2300 RC Leiden, The Netherlands

4. Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-sufficient primary natural killer cells engineered to express T cell receptors and interleukin-15 exhibit improved effector function and persistence;Frontiers in Immunology;2024-04-16

2. Immune cells in the B-cell lymphoma microenvironment: From basic research to clinical applications;Chinese Medical Journal;2024-01-25

3. High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRs;Journal of Biological Chemistry;2023-08

4. Multi-tiered approach to detect autoimmune cross-reactivity of therapeutic T cell receptors;Science Advances;2023-07-28

5. PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer;Frontiers in Immunology;2023-03-21